OTAVA-BB BB7020410393 - Names and Identifiers
OTAVA-BB BB7020410393 - Physico-chemical Properties
Molecular Formula | C15H27Cl2N3O
|
Molar Mass | 336.3 |
Storage Condition | Room Temprature |
Sensitive | Irritant |
MDL | MFCD08443671 |
OTAVA-BB BB7020410393 - Risk and Safety
Hazard Symbols | Xi - Irritant

|
Hazard Class | IRRITANT |
OTAVA-BB BB7020410393 - Introduction
2-(4-Ethyl-piperazin-1-yl)-2-(4-methoxy-phenyl)-ethylamine dihydrochloride, also known as 2-(4-Ethyl-piperazin-1-yl)-2-(4-methoxy-phenyl)-ethylamine dihydrochloride, is an organic compound. The following is a description of the properties, uses, preparation and safety information of this compound:
Nature:
-Appearance: A white or off-white crystalline solid.
-Molecular formula: C18H29Cl2N3O.
-Molecular weight: 372.358g/mol.
-Melting point: about 175-185°C.
-Solubility: Soluble in water and some organic solvents, such as methanol and dimethyl sulfoxide.
Use:
- 2-(4-Ethyl-piperazin-1-yl)-2-(4-methoxy-phenyl)-ethylamine dihydrochloride have a wide range of applications in the field of medicine.
-It is a dopamine D2 receptor antagonist and can be used as an intermediate for antipsychotic drugs.
-In research, it can also be used to prepare biologically active organic compounds.
Preparation Method:
- 2-(4-Ethyl-piperazin-1-yl)-2-(4-methoxy-phenyl)-ethylamine dihydrochloride can be prepared by organic synthesis in multiple steps.
-A commonly used method uses 4-methoxyphenylacetaldehyde as the starting material and undergoes a suitable reaction to produce the target compound.
Safety Information:
-Because 2-(4-Ethyl-piperazin-1-yl)-2-(4-methoxy-phenyl)-ethylamine dihydrochloride has applications in the medical field, it is generally safe for humans under correct use and storage.
-However, as a chemical, appropriate laboratory procedures and safety measures must be taken to prevent contact with skin, eyes and respiratory tract.
-When using and handling this compound, follow the relevant safety procedures and properly dispose of waste in hazardous materials.
Last Update:2024-04-09 02:00:56